- Home
- ZGN vs ARWR Comparison
ZGN vs ARWR Comparison
Compare ZGN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- ARWR
- Stock Information
- Founded
- ZGN 1910
- ARWR 2003
- Country
- ZGN Italy
- ARWR United States
- Employees
- ZGN N/A
- ARWR N/A
- Industry
- ZGN Apparel
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- ZGN Consumer Discretionary
- ARWR Health Care
- Exchange
- ZGN Nasdaq
- ARWR Nasdaq
- Market Cap
- ZGN 1.9B
- ARWR 1.7B
- IPO Year
- ZGN N/A
- ARWR 1993
- Fundamental
- Price
- ZGN $8.03
- ARWR $13.25
- Analyst Decision
- ZGN Buy
- ARWR Buy
- Analyst Count
- ZGN 2
- ARWR 11
- Target Price
- ZGN $8.05
- ARWR $41.44
- AVG Volume (30 Days)
- ZGN 1.0M
- ARWR 2.2M
- Earning Date
- ZGN 03-27-2025
- ARWR 05-08-2025
- Dividend Yield
- ZGN 1.72%
- ARWR N/A
- EPS Growth
- ZGN N/A
- ARWR N/A
- EPS
- ZGN 0.31
- ARWR N/A
- Revenue
- ZGN $2,015,371,157.00
- ARWR $2,500,000.00
- Revenue This Year
- ZGN $2.59
- ARWR $4,380.43
- Revenue Next Year
- ZGN $5.71
- ARWR $64.24
- P/E Ratio
- ZGN $24.18
- ARWR N/A
- Revenue Growth
- ZGN 2.21
- ARWR N/A
- 52 Week Low
- ZGN $6.05
- ARWR $9.57
- 52 Week High
- ZGN $13.36
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- ZGN 64.42
- ARWR 50.85
- Support Level
- ZGN $6.82
- ARWR $10.92
- Resistance Level
- ZGN $7.15
- ARWR $13.45
- Average True Range (ATR)
- ZGN 0.40
- ARWR 1.10
- MACD
- ZGN 0.17
- ARWR 0.41
- Stochastic Oscillator
- ZGN 99.75
- ARWR 94.85
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.